KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $91,997,000 | -2.5% | 9,496 | 0.0% | 0.05% | +96.3% |
| Q1 2022 | $94,384,000 | -22.2% | 9,496 | -7.9% | 0.03% | -6.9% |
| Q4 2021 | $121,309,000 | -1.1% | 10,307 | -4.3% | 0.03% | 0.0% |
| Q3 2021 | $122,700,000 | -6.6% | 10,773 | +13.3% | 0.03% | -3.3% |
| Q2 2021 | $131,356,000 | +8.1% | 9,505 | +44.8% | 0.03% | -14.3% |
| Q1 2021 | $121,494,000 | -12.6% | 6,564 | -16.5% | 0.04% | -14.6% |
| Q4 2020 | $138,933,000 | +71.7% | 7,863 | +48.8% | 0.04% | +78.3% |
| Q3 2020 | $80,931,000 | -25.3% | 5,283 | +24.3% | 0.02% | -20.7% |
| Q2 2020 | $108,283,000 | +18.8% | 4,250 | -27.8% | 0.03% | +16.0% |
| Q1 2020 | $91,173,000 | – | 5,890 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |